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Introduction: Idiopathic acute eosinophilic pneumonia (AEP) is characterized by hypoxemia, pulmonary
inﬁltrates and pulmonary eosinophilia. Data is limited and the purpose of this study is to better un-
derstand this disorder.
Methods: A search of the computerized patient records from January 1, 1997 to October 15, 2010 for
patients with suspicion of “eosinophilic pneumonia” was conducted. Included patients were 18 years or
older with an acute febrile illness, hypoxemia, diffuse pulmonary inﬁltrates on imaging, and pulmonary
eosinophilia. Patients were excluded with other known causes of pulmonary eosinophilia.
Results: Of 195 patients with pulmonary eosinophilia, 8 patients had “deﬁnite” or “probable” and 4
patients had “possible” idiopathic AEP. Three patients were categorized as “probable” idiopathic AEP due
to exceeding expected maximal 30-day symptom duration and/or a maximal recorded temperature less
than 38 C. Four patients were deﬁned as “possible” idiopathic AEP given histories of polymyalgia
rheumatica, eczema or allergic rhinitis. Of the 8 included patients, 63% were male with a median age of
53. Median duration of symptoms was 21 days. Median nadir oxygen saturation was 83%. Median
eosinophil count on bronchoalveolar lavage was 36%. Two patients required intubation. Two patients
were current smokers, one of whom had reported a change in smoking habits. All patients were treated
with steroids (median of two months).
Conclusions: As diagnostic methods and pharmacologic knowledge improve, the number of patients
meeting criteria for idiopathic AEP remains small. Much remains to be learned about this truly rare
condition, and current criteria may exclude milder presentations of the disease.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Acute eosinophilic pneumonia (AEP) is a rare disorder marked
by hypoxemia, pulmonary inﬁltrates and pulmonary eosinophilia
[1,2]. AEP occurs secondary to medications or hypersensitivity
reactions to an inhaled antigen (such as tobacco smoke) [3e8].
Hematopoietic stem transplant and autoimmune diseases areon: Presented at the CHEST
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r Ltd. Open access under CC BY-NC-NDassociated with eosinophilic lung disease and also need to be
distinguished from idiopathic AEP [1,9].
Current data on idiopathic AEP is limited. Diagnostic criteria
vary but typically include an acute febrile illness, hypoxemic
respiratory failure, diffuse pulmonary inﬁltrates on imaging, and
pulmonary eosinophilia with exclusion of known causes of
pulmonary eosinophilia [2]. Reported case series demonstrate
variations in duration of illness, deﬁnition of fever (or docu-
mentation of anti-pyretic use), deﬁnition of pulmonary eosin-
ophilia, documentation of hypoxia and exclusion of atopy,
allergic rhinitis and asthma [2,8,10e12]. The extent to which
known causes of pulmonary eosinophilia were excluded also
varies.
We performed a single-center retrospective case review and
literature review to summarize available data. Our objective was to
focus on idiopathic AEP (by carefully excluding known causes of
pulmonary eosinophilia) and examining disease characteristics in
our series and prior reports. license.
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This protocol was approved by the Institutional Review Board
(#10-006298). We searched the computerized medical records from
January 1,1997 to October 15, 2010 of patients consenting to research
for the term “eosinophilic pneumonia”. Those patientswere screened
for presence of pulmonary eosinophilia (demonstrated eosinophils
on lung biopsy or BAL with >25% eosinophils) [2,10]. Patients met
criteria for inclusion if aged 18 years or older with an acute febrile
illness (<45 days in duration), hypoxemia or desaturation (nadir
oxygen saturation (SpO2) < 90% or PaO2 <60 mm Hg), diffuse pul-
monary inﬁltrates on chest imaging (chest radiograph or chest
computed tomography), and pulmonary eosinophilia (as deﬁned
above). Patientswere excludedwithasthmaorotherknowncauses of
pulmonary eosinophilia. Patients meeting these criteria were cate-
gorized as “deﬁnite” idiopathic AEP. Patients with a maximal tem-
perature of 37.2 BC or above (but less than 38.0 BC) without
subjective fevers or illness duration greater than 30 days were char-
acterized as “probable” idiopathic AEP. Charts were reviewed for
demographics, laboratory and imaging ﬁndings, and clinical course.
3. Results
195 patients with suspected “eosinophilic pneumonia” demons
trated pulmonary eosinophilia (as deﬁned above). Of these 195, 12
patients were included and 183 were excluded for various reasons
(see Fig. 1). Thirteen patients were excluded due to relapse of
symptoms on steroid taper and 2 patients were excluded due to1060 patients screened with 
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Fig. 1. Trial ﬂow includinglack of diffuse inﬁltrates on chest imaging. Five patients had all
characteristics consistent with the diagnosis of idiopathic AEP.
Three patients were categorized as “probable” idiopathic AEP due
to exceeding expected 30-day symptom duration (37 and 38 days)
and/or maximal temperature less than 38 BC and are included in
analysis. Four patients were deﬁned as “possible” idiopathic AEP
given history of polymyalgia rheumatica, eczema or allergic rhinitis
and are described but not included in analysis. Clinical features of
included patients are summarized in Table 1 and Table 2.
4. Discussion
4.1. Presenting symptoms
While idiopathic AEP is by deﬁnition an acute illness, the
symptom duration has been variably deﬁned as less than 7 [11] or
less than 30 days [2] without signiﬁcant differences in the clinical
manifestations. We examined all cases of possible idiopathic AEP of
less than 45 days duration and describe two cases with symptoms
slightly longer than 30 days as “probable” AEP. Although it can
be argued that a longer duration of symptoms may lead to confu-
sion with chronic eosinophilic pneumonia, the average duration
of symptoms in chronic eosinophilic pneumonia is signiﬁcantly
longer (19.7 weeks) and the disease characteristics are distinct [13].
Likewise the deﬁnition of “febrile illness” varies in the reported
literature including temperatures as low as 37.2 C [6,12]. We used
subjective fevers or a temperature of 38 C. We have included one
patient without fever who was using anti-pyretic agents. Littleymptoms
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Table 1
Description of cases at our institution.
Patient Age at
diagnosis
Sex Maximal
temperature
(celsius)
Fevers or
chills
Nadir
SpO2 (%)
Symptom
duration
(days)
Bilateral
inﬁltrates
modality
BAL
eosinophils (%)
Eosinophils
present on
biopsy
1 45 M 38.6 Yes 79 7 CXR 53 Yes
2 32 F 37.6 Yes 68 15 CT 34 Not performed
3 61 M 39.7 Yes 83 4 CXR 9 Yes
4 74 M 37.8 Yes 85 21 CXR 42 Yes
5 76 M 37.4 Yes 86 21 CXR 37 No
6 19 F 39.0 Yes 61 38 CXR 28 Not performed
7 79 F 37.5 No 82 37 CXR 20 Yes
8 22 M 37.2 No 83 30 CXR 87 Yes
9a 73 F 38.0 No 81 7 CT 6 Yes
10b 72 M 37.0 Yes 89 14 CXR 80 Not performed
11c 57 M 37.3 Yes 83 35 CT Not performed Yes
12d 22 M 38.7 Yes 88 2 CXR 60 Not performed
Patients whomeet all criteria for idiopathic acute eosinophilic pneumonia (cases 1e5), probable idiopathic acute eosinophilic pneumonia (cases 6e8), or possible eosinophilic
pneumonia despite history of atopic disease (cases 9e12). CXR: chest radiograph. CT: Computed tomography.
a Patient with history of polymyalgia rheumatica.
b Patient with history of polymyalgia rheumatica.
c Patient with history of eczema, rheumatoid arthritis.
d Patient with history of allergic rhinitis (required intubation).
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agents or cooling device use in prior reported cases. Furthermore,
patients with sepsis may have an abnormally low temperature in
lieu of fever. It is unknown if this is also true of AEP as such patients
have by deﬁnition been excluded from AEP criteria. With this in
mind clinicians should consider AEP in patients in the absence of
fever if other features are compatible.
Hypoxemia has been typically described as a PaO2 less than
60 mm Hg or a pulse oximetry saturation of less than 90% on room
air [2]. However, one recent case series did not use hypoxia/hyp-
oxemia as an inclusion criteria for potential cases of idiopathic AEP
[12]. In reviewing the literature, little attention has been paid to
desaturation with activity. Some of our patients did not have hyp-
oxia at rest but had hypoxia with minimal exertion. Desaturation
with activity should be considered as a criterion for AEP. In patients
without hypoxia but with other classic features AEP should be
considered.
Pulmonary eosinophilia is perhaps the most straightforward
criteria. Our case series included cases diagnosed by lung biopsy or
by BAL consistent with prior reports [2,10]. Interestingly one prior
report described a patient with a low eosinophil count on bronchial
wash with a subsequent elevated BAL eosinophil count [14]. This
emphasizes the need for a formal BAL in order to assure accurate
diagnostics.
Finally, Philit et al. described “bilateral diffuse inﬁltrates on chest
radiography” as a criterion for AEP [2]. Others have included “diffuse
pulmonary inﬁltrates” without stipulating type of imaging or
bilateral nature [12].Wehave included diffuse pulmonary inﬁltratesTable 2
Summary of clinical features of deﬁnite and probable idiopathic AEP cases at our
institution.
Age 53 years old (19e79)
Male 63%
Duration of symptoms 21 days (4e38)
Maximum temperature 37.7 C (37.2e39.7)
Nadir SpO2 83% (61e86)
White blood cell count on admission (109/L) 13.2 (7.3e27.8)
Eosinophil count on admission (109/L) 0.34 (0.01e10.56)
BAL eosinophils 36% (9e87)
Duration of hospitalization 7 days (1e12)
Intubation 25% (1e3 days)
Duration of steroids therapy 60 days (35e285)
All numbers above are median (range) unless otherwise noted.by either chest CT or CXR in our inclusion criteria and believe cli-
nicians should use similar criteria in considering this diagnosis.
4.2. Exclusion of “causes of pulmonary eosinophilia”
Perhaps themost controversial decision is whether to include or
exclude patients with atopy or asthma from the case series. Some
authors have proposed that patients with atopy have a predispo-
sition to AEP [14] while others have excluded such patients as
having an alternate explanation of pulmonary eosinophilia.4 We
have highlighted in Table 3 the variability in the literature regarding
atopy inclusion. We did not include asthmatic patients and have
deemed those with allergic rhinitis or atopy as “possible” cases of
AEP. Given the controversy, clinicians should be aware that atopy
and asthma are not universally considered exclusive of AEP.
4.3. Disease severity
Our case series demonstrates variation in disease severity with
only two patients requiring intubation for respiratory failure.
Approximately 16% of all reported patients required intubation
(Table 3). We do not report any deaths, shock, or extra-corporeal
membrane oxygenation use but such reports exist in the litera-
ture [8,14e19]. Conversely many case series include patients with
spontaneous resolution without steroid use [2,6,20,21]. All of our
patients received some duration of corticosteroid therapy.
4.4. Treatment
Treatment in our case series ranged from 35 to 285 days of
corticosteroid taper with a median duration of 60 days. The litera-
ture also contains a spectrum of treatment regimens from 125 mg
methylprednisolone every six hours followed by prolonged steroid
taper to no treatment at all. Although not demonstrated in our
current case series, a recent retrospective report byRhee et al. seems
to support a two-week duration of corticosteroid treatment [12].
4.5. Relapses
It is believed that relapse is not consistent with a diagnosis of
AEP [1,20] and therefore we excluded 13 patients from our case
series with relapse of symptoms. It should be noted however that
Table 3
Summary of available IAEP case-series.
Number of
patients
Male Female Age Current
smokers
Number requiring
intubation
BAL eosinophils % Patients with atopic
disease/asthma included
Allen et al., 1989 [23] 4 3 1 34 (Mean) Unclear 2/4 42 (Mean) No asthma
Umeki et al., 1992 [24] 5 4 1 37.7 (Mean) 3/5 Unclear 20.3 (Mean for 3 patients) Yes
Ogawa et al., 1993 [21] 5 5 0 28.2 (Mean) 3/5 Unclear 42.4 (Mean) Yes
Hayakawa et al., 1994 [20] 13 9 4 37.2 (Mean) Unclear Unclear 40.3 (Mean) Yes
Cheon et al., 1996 [25] 6 4 2 29 (Mean) 1/5 Unclear Unclear No
Pope-Harman et al., 1996 [11] 15 9 6 28.9 (Mean) 6/15 8/15 36.9 (Mean) Unclear
Tazelaar et al., 1997 [10] 9 4 5 53 (mean) 3/9 Unclear 1 (Only 1 patient
underwent BAL)
Yes
Shiota et al., 2000 [22] 2 2 0 23 (Mean) 2/2 0/2 47 (Mean) No
Philit et al., 2002 [2] 22 13 9 29 (Mean) 8/22 8/22 54.4 (mean) Yes
Shorr et al., 2004 [8] 18 16a 2 22 (Median) 18/18 12/18 40.5 (Median) Unclear
Miyazaki et al., 2007 [26] 17 11 6 19 (Median) 16/17 0/17 65 (Median) Yes
Daimon et al., 2008 [27] 29 14 15 26 (Mean) Unclear Unclear Unclear No
Uchiyama et al., 2008 [6] 33 23 10 19.3 (Mean) 32/33 Unclear 52.8 (Mean) Yes
Rhee et al., 2013 [12] 137 137a 0 20 (Median) 135/137 3/137 40 (Median) Yes
Our study 8 5 3 53 (Median) 2/8 2/8 36 (Median) No
Total 323 259 64 n/a 229/276 35/223 Range 1e54.4% At least 8 studies
a Military personnel study.
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provocation test in AEP patients [6,7]. Clinicians should be aware of
this potential when counseling their patients.
4.6. Sex and age trends
Approximately 80% of reported patients are males (Table 3). It is
unclear whether this reﬂects smoking or occupational differences
by gender (for example, two case series are of military personnel
[8,12]) or an actual tendency. Likewise young age has been previ-
ously reported, however, the oldest patient in our case series is 79-
years old. This suggests the diagnosis should be considered
regardless of age in patients with pulmonary inﬁltrates of non-
infectious etiology.
4.7. Smoking history
Interestingly the patients in our series did not have a new or
increased smoking history contrary to prior published associations
[2,6e8]. Eighty-three percent of all reported patients are current
smokers (Table 3). It is difﬁcult to differentiate between new-onset
smokers or individuals with alterations in smoking habits due to
reporting styles and differing cutoffs in the articles presented. Only
one of our eight patients had recently altered smoking habits (pa-
tient 6). So while smoking is a known association, individuals who
lack this history should not be discounted.
5. Conclusions
Idiopathic AEP is a truly rare condition comprising approxi-
mately 4% of cases of pulmonary eosinophilia at our institution.
Inclusion criteria vary but consideration should be made for pa-
tients with pulmonary eosinophilia by BAL or biopsy and diffuse
pulmonary inﬁltrates. Other criteria include approximately one
month of symptoms, desaturation at rest or with exercise, and
subjective or objective fevers. Not all reported cases appear to
meet all criteria and disease severity can range from self-resolving
to fatal. Idiopathic AEP should remain in the differential regardless
of age, sex, or smoking association although these remain diag-
nostic clues.
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